Retinoids: new use by innovative drug-delivery systems

Bibliography

• Boehm MF, Heyman RA, Patel S, et al. Retinoids: biological function and use in the treatment of dermatological diseases. Expert Opin Invest Drugs 1995;4:593-612
   Google Scholar
• Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008;134:921-31
   PubMed Web of Science ®Google Scholar
• Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 2003;143-144:201-10
   PubMed Web of Science ®Google Scholar
• Xu XC. Tumor-suppressive activity of retinoic acid receptor-beta in cancer. Cancer Lett 2007;253:14-24
   PubMed Web of Science ®Google Scholar
• Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses: new insights into coordinated regulation of the PPAR-RXR complex. FEBS Lett 2008;582:32-8
   PubMed Web of Science ®Google Scholar
• Nagy L, Kao HY, Love JD, et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 1999;13:3209-16
   PubMed Web of Science ®Google Scholar
• Perissi V, Staszewski LM, Mcinerney EM, et al. Molecular determinants of nuclear receptor/corepressor interaction. Genes Dev 1999;13:3198-208
   PubMed Web of Science ®Google Scholar
• Wolf G. Cellular retinoic acid-binding protein II: a coactivator of the transactivation by the retinoic acid receptor complex RAR.RXR. Nutr Rev 2000;58:151-3
   PubMed Web of Science ®Google Scholar
• Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther 2006;19:272-9
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof PC. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther 2006;19:252-63
   PubMed Web of Science ®Google Scholar
• Lens M, Medenica L. Systemic retinoids in chemoprevention of non-melanoma skin cancer. Expert Opin Pharmacother 2008;9:1363-74
   PubMed Web of Science ®Google Scholar
• McCaffery P, Simons C. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity. Curr Pharm Des 2007;13:3020-37
   PubMed Web of Science ®Google Scholar
• Bogos K, Renyi-Vamos F, Kovacs G, et al. Role of retinoic receptors in lung carcinogenesis. J Exp Clin Cancer Res 2008;14:27-18
   Google Scholar
• Li Y, Zhang Y, Hill J, et al. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice. Br J Cancer 2008;98:1380-8
   PubMed Web of Science ®Google Scholar
• Kawin L, Kenoki O, Kazuhiro M, et al. All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett 2005;224:303-10
   PubMed Web of Science ®Google Scholar
• Guo J, Xiao B, Lou Y, et al. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells. J Gastroenterol Hepatol 2006;21:443-8
   PubMed Web of Science ®Google Scholar
• Kunynetz RA. A Review of Systemic Retinoid Therapy for Acne and Related Conditions. Skin Therapy Lett 2004;9:1-4
   PubMedGoogle Scholar
• Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging 2006;1:327-48
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Cilurzo F, Fresta M. Innovative drug delivery systems for the administration of natural compounds. Curr Bioactive Compounds 2007;3:262-77
   Google Scholar
• Brisaert M, Gabriëls M, Matthijs V, Plaizier-Vercammen J. Liposomes with tretinoin: a physical and chemical evaluation. J Pharm Biomed Anal 2001;26:909-17
   PubMed Web of Science ®Google Scholar
• Cortesi R, Esposito E, Gambari R, et al. Liposome-associated retinoids: production and antiproliferative activity on neoplastic cells. Eur J Pharm Sci 1994;2:281-91
   Web of Science ®Google Scholar
• Ioele G, Cione E, Risoli A, et al. Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int J Pharm 2005;293:251-60
   PubMed Web of Science ®Google Scholar
• Sinico C, Manconi M, Peppi M, et al. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release 2005;103:123-36
   PubMed Web of Science ®Google Scholar
• Manconi M, Marongiu F, Ennas G, et al. Liposomes for (trans)dermal delivery of tretinoin: influence of drug concentration and vesicle composition. J Drug Del Sci Tech 2008;18:309-13
   Web of Science ®Google Scholar
• Montenegro L, Panco AM, Ventimiglia A, Bonina F. In vitro retinoic acid release and skin permeation from different liposome formulations. Int J Pharm 1996;133:89-96
   Web of Science ®Google Scholar
• Kitagawa S, Kasamaki M. Enhanced delivery of retinoic acid to Skin by cationic liposomes. Chem Pharm Bull 2006;54:242-44
   PubMed Web of Science ®Google Scholar
• Kawakami S, Suzuki S, Yamashita F, Hashida M. Induction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomes. J Control Release 2006;110:514-21
   PubMed Web of Science ®Google Scholar
• Suzuki S, Kawakami S, Chansri N, et al. Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes. J Control Release 2006;116:58-63
   PubMed Web of Science ®Google Scholar
• Shimizu K, Tamagawa K, Takahashi N, et al. Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside misture. Int J Pharm 2003;258:45-53
   PubMed Web of Science ®Google Scholar
• Shimizu K, Qi XR, Maitani Y, et al. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models. Biol Pharm Bull 1998;21:741-46
   PubMed Web of Science ®Google Scholar
• Díaz C, Vargas E, Gätjens-Boniche O. Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. Int J Pharm 2006;325:108-15
   PubMed Web of Science ®Google Scholar
• Hashida M, Nishikawa M, Yamashita F, Takakura Y. Cell-specific delivery of genes with glycosilated carriers. Adv Drug Deliv Rev 2001;52:187-96
   PubMed Web of Science ®Google Scholar
• Nastruzzi C,Walde P, Menegatti E, Gambari R. Liposome-associated retinoic acid. Increased in vitro anti-proliferative effects on neoplastic cells. FEBS Lett 1990;259:293-96
   PubMed Web of Science ®Google Scholar
• Tallman MS, Andersen JW, Schiffer CA, et al. All trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 1997;337:1021-28
   PubMed Web of Science ®Google Scholar
• Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-200
   PubMed Web of Science ®Google Scholar
• Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002;100:4298-302
   PubMed Web of Science ®Google Scholar
• Parthasarathy R, Metha K. Altered metabolism of all-trans-retinoic acid in liposome encapsulated form. Cancer Lett 1998;134:121-28
   PubMed Web of Science ®Google Scholar
• Douer D, Estey E, Santillana S, et al. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 2001;97:73-80
   PubMed Web of Science ®Google Scholar
• Westervelt P, Pollock JL, Oldfather KM, et al. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leucemia. PNAS 2002;99:9468-73
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Lopez-Berestein G, Adamson P, et al. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered atra in healthy volunteers. J Pharm Pharmaceut Sci 2003;6:292-301
   PubMed Web of Science ®Google Scholar
• Mehta K, Sadeghi T, Mcqueen T, Lopez-Berestein G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk Res 1994;18:587-96
   PubMed Web of Science ®Google Scholar
• Estey E, Koller C, Tsimberidou AM, et al. Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid. Blood 2005;105:1366-67
   PubMed Web of Science ®Google Scholar
• Cosco D, Celia C, Cilurzo F, et al. Colloidal carriers for the enhanced delivery through the skin. Expert Opin Drug Deliv 2008;5:737-55
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 2002;234:237-48
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Coll Interf Sci 1995;58:1-55
   Web of Science ®Google Scholar
• Manconi M, Valenti D, Sinico C, et al. Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003;260:261-72
   PubMed Web of Science ®Google Scholar
• Brisaert M, Plaizier-Vercammen J. Investigation on the photostability of a tretinoin lotion and stabilization with additives. Int J Pharm 2000;199:49-57
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Valenti D, et al. Niosomes as carriers for tretinoin III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 2006;311:11-9
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm 2003;258:141-51
   PubMed Web of Science ®Google Scholar
• Desai TR, Finlay WH. Nebulization of niosomal all-trans-retinoic acid: an inexpensive alternative to conventional liposomes. Int J Pharm 2002;241:311-17
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Soo-Jeong L, Mi-Kyung L, Chong-Kook K. Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J Control Release 2004;100:53-61
   PubMed Web of Science ®Google Scholar
• Hogan CJ, Wiley JS, Billington T. Intravascular haemolysis complicating treatment of acute promyelocytic leukaemia with all-trans retinoic acid (ATRA). Aust N Z J Med 1997;27:450-51
   PubMedGoogle Scholar
• Lim SJ, Kim KK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135-46
   PubMed Web of Science ®Google Scholar
• Shah KA, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm 2007;345:163-71
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007;328:191-95
   PubMed Web of Science ®Google Scholar
• Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: Application to topical delivery of tretinoin. Int J Pharm 2008;363:132-8
   PubMed Web of Science ®Google Scholar
• Aliabadi HM, Lavasanifar A. Polymeric micelles for drug delivery. Expert Opin Drug Deliv 2006;3:139-62
   PubMedGoogle Scholar
• Paolino D, Sinha P, Fresta M, Ferrari M. Drug delivery systems. In: Webster JG, editor, The encyclopedia of medical devices and instrumentations. 2nd edition. John Wiley & Sons, New Jersey. 2006. p.437-95
   Google Scholar
• Kim IS, Kim SH. Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety. Int J Pharm 2003;257:195-203
   PubMed Web of Science ®Google Scholar
• Seo SJ, Moon HS, Guo DD, et al. Receptor-mediated delivery of all-trans-retinoic acid (ATRA) to hepatocytes from ATRA-loaded poly(N-p-vinylbenzyl-4-o-β-D-galactopyranosyl-d-gluconamide) nanoparticles. Mat Sci Eng C 2006;26:136-41
   Google Scholar
• Kim DG, Jeong YI, Choi C, et al. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. Int J Pharm 2006;319:130-38
   PubMed Web of Science ®Google Scholar
• Opanasopit P, Ngawhirunpat T, Rojanarata T, et al. N-Phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles. Eur J Pharm Sci 2007;30:424-31
   PubMed Web of Science ®Google Scholar
• Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int J Pharm 2008;352:1-4
   PubMed Web of Science ®Google Scholar
• Hwang SR, Lim SJ, Park JS, Kim CK. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int J Pharm 2004;276:175-83
   PubMed Web of Science ®Google Scholar
• Yap KL, Liu X, Thenmozhiyal JC, Ho PC. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur J Pharm Sci 2005;25:49-56
   PubMed Web of Science ®Google Scholar
• Anadolu RY, Sen T, Tarimci N, et al. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex. JEADV 2004;18:416-21
   Google Scholar
• Yamaguchi Y, Nagasawa T, Nakamura N, et al. Successful treatment of photo-damaged skin of nano-scale ATRA particles using a novel transdermal delivery. J Controll Release 2005;104:29-40
   PubMed Web of Science ®Google Scholar
• Redmond KA, Nguyen TS, Ryan RO. All-trans-retinoic acid nanodisks. Int J Pharm 2007;339:246-50
   PubMed Web of Science ®Google Scholar
• Availiable from: http://www.fda.gov/orphan/
   Google Scholar